Iroko Pharmaceuticals Inc
150 Rouse Boulevard, Philadelphia, PA 19112-1901
Related Posts:
July 15, 2015
Iroko Pharmaceuticals Inc., today announced it has entered into a licensing agreement with Laboratorios Saval for the exclusive rights to market and sell Zorvolex capsules in an additional five South American countries. Zorvolex is approved in the U.S.
Read more →
Sign-up for the Weekly Newsletter from Latin Business Daily.